Literature DB >> 22056864

Central serous chorioretinopathy following oral tadalafil.

P Gordon-Bennett, T Rimmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22056864      PMCID： PMC3259586          DOI： 10.1038/eye.2011.250

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study.

Authors:  Dustin D French; Curtis E Margo
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

2.  Choroidal capillary and venous congestion in central serous chorioretinopathy.

Authors:  C Prünte; J Flammer
Journal:  Am J Ophthalmol       Date:  1996-01       Impact factor: 5.258

3.  Retinal effects of 6 months of daily use of tadalafil or sildenafil.

Authors:  William H Cordell; Raj K Maturi; Timothy M Costigan; Michael F Marmor; Richard G Weleber; Stuart G Coupland; Ronald P Danis; John W McGettigan; Andrew N Antoszyk; Suzanne Klise; Gregory D Sides
Journal:  Arch Ophthalmol       Date:  2009-04
  3 in total
  5 in total

1.  Authorship and the role of medical writers.

Authors:  A J Lotery
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

Review 2.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

3.  Central serous chorioretinopathy due to tadalafil use.

Authors:  Fatih Mehmet Türkcü; Harun Yüksel; Alparslan Şahin; Mehmet Murat; Yaşar Bozkurt; Ihsan Çaça
Journal:  Int Ophthalmol       Date:  2012-10-14       Impact factor: 2.031

Review 4.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

Review 5.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Drug Des Devel Ther       Date:  2016-10-19       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.